Research must for new tech in medicine: Pathak
Pathak said, 'New medicine, implants and technology are required and CBMR is playing a vital role in this. CBMR is being developed as a national translational research institute. To increase patents research and collaboration with international institutes should be given preference.'
Pathak lauded the centre's role in advancing neuroimaging, biomarker discovery, drug discovery, molecular diagnostics, translational medicine, and its commitment to developing affordable healthcare solutions.
Professor Alok Dhawan, director of CBMR, presented a detailed report highlighting the institute's achievements over the past year. He underlined the Centre's increasing focus on IPR generation, innovation ecosystems, and cross-disciplinary partnerships with both national and international institutions. He reiterated CBMR's mission to support affordable, accessible, and advanced healthcare solutions through sustained scientific inquiry and innovation.
On the occasion, the 'CBMR Research Publication Award' was conferred to elevate and encourage the culture of high-impact scientific research among CBMR faculty members. As the guest of honour, professor Sanjeev Misra, vice-chancellor of Atal Bihari Vajpayee Medical University (ABVMU), Lucknow, felicitated six distinguished faculty members of CBMR with this prestigious award, acknowledging their contributions and achievements in biomedical research.
During the function, memoranda of understanding (MoUs) were signed between the CBMR and four prestigious institutions—Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow; Central Council for Research in Homoeopathy (CCRH), New Delhi; AIIMS – Rae Bareli and Amity University Lucknow Campus. These collaborations are expected to significantly strengthen CBMR's capacity for impactful translational research.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
a day ago
- Time of India
Brajesh Pathak presents roadmap to make UP number one in every sector
1 2 Lucknow: Deputy Chief Minister Brajesh Pathak on Wednesday presented the 'health vision document' in the Assembly. He outlined the govt's ambitious roadmap to make the state number one in every sector, particularly healthcare. Pathak said the vision of 'Viksit Bharat 2047' goes beyond infrastructure such as buildings and roads. It encompasses ensuring health, dignity, and equitable opportunities for every citizen. "Prime Minister Narendra Modi is advancing on the path of development guided by the mantra of 'Sabka Saath, Sabka Vikas, Sabka Vishwas, Sabka Prayas'. Our priority is to provide quality healthcare to all without financial hardship," he told the House. The document presented the govt's goals, achievements, and policy priorities for 2027, 2030, and 2047. Pathak said the National Health Policy 2017, which focuses on affordable, quality healthcare for all, preventive care, and primary health services, forms the core of state policy. Under the Ayushman Bharat scheme, each family receives annual coverage of up to Rs 5 lakh. Uttar Pradesh, Pathak said, emerged as a frontrunner in implementing the scheme, along with the Ayushman Bharat Digital Mission, Ayushman Bharat Health Infrastructure Mission, and eSanjeevani telemedicine services. By 2027, the govt aims to provide treatment coverage to every family, achieve 100% e-KYC for eligible households under PM-JAY, distribute gold cards, integrate state-level fraud risk monitoring with helplines, and expand digitisation across the health sector. All Ayushman Arogya Mandirs will be equipped with biomedical lab networks, and public health laboratories will be strengthened. Greater use of telehealth services and expansion of medical education are also planned. By 2030, targets include reducing maternal and infant mortality rates, improving disease control, and raising the quality of medical education. So far, 5.34 crore Ayushman cards have been issued under the Pradhan Mantri Jan Arogya Yojana and the Mukhyamantri Jan Arogya Yojana, benefiting 70.36 lakh patients with free treatment worth Rs 11,123 crore. The state has also established Ayushman Arogya Mandirs and launched special drives against communicable diseases. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.
Hindustan Times
a day ago
- Hindustan Times
UP will have an active role in medical tourism, pharma output: Brajesh Pathak
LUCKNOW Deputy chief minister Brajesh Pathak on Wednesday said that super speciality hospitals and trauma centres will be set up in every division, with disease surveillance systems to tackle ailments like diabetes, hypertension and cancer, alongside awareness drives on health risks from climate change. Deputy chief minister Brajesh Pathak said healthcare services have seen remarkable progress, with 80 medical colleges, AIIMS in Rae Bareli and Gorakhpur and more than 5,250 MBBS seats. (File Photo) 'Developed India 2047 isn't limited to infrastructure, but includes health of every citizen. Not just in health, UP will become number one in every sector,' he said while presenting the 'Health Vision Document' during a historic 24-hour debate on 'Vision 2047' on the third day of the UP Assembly's Monsoon Session. 'Healthcare services have seen remarkable progress, with 80 medical colleges, AIIMS in Rae Bareli and Gorakhpur and more than 5,250 MBBS seats,' he said. 'Under the Ayushman Bharat scheme, 5.5 crore health cards have been made. Mosquito-borne diseases have been brought under control and the target is to completely eradicate TB, malaria and water-borne diseases. Before 2017, UP's infrastructure and law and order were in disarray, with serious crimes enjoying political protection. Today, the state boasts the most expressways in the country, four-lane road links to all 75 districts and improved power supply across all regions compared to just five districts earlier,' he said. Presenting the action plan of the government's vision, achievements, policy priorities for 2027-2030-2047 for health department, the deputy CM informed the House that the Prime Minister has clarified in the context of Developed India 2047 that the path to reach this goal is through minimum government interference, maximum ease and a healthy India. He informed that the National Health Policy 2017's quality health services for all without financial hardship and prevention-oriented primary care are the pivot of government's policies. Giving information about the targets till 2027, the deputy CM said that treatment security will be provided to every family, e-KYC of 100% eligible families in PMJAY, gold card distribution, fraud risk monitoring at the state level and integration of helpline will be done. Promotion of digitalisation in the field of health, biomedical lab network in all Ayushman Arogya Mandirs, public health laboratories will also be strengthened. Sharing measurable targets for 2030, Pathak said: 'More attention will be paid to disease control, quality of medical education and reduction of maternal-infant mortality rate. UP will have an active role in medical tourism, pharma production, biotech innovation in line with Prime Minister Narendra Modi's One Earth, One Health vision. There will be emphasis on public participation and good governance.'
Time of India
3 days ago
- Time of India
Anti-aging and stem cell research gains momentum in India's healthcare sector
The landscape of health and longevity in India is witnessing a quiet but profound transformation, driven by advancements in regenerative medicine, particularly stem cell research. What was once considered a speculative area of science is now demonstrating tangible results, fostering a new perspective on aging not merely as an inevitable decline but as a process amenable to management and enhancement. This evolving narrative is being shaped by both personal anecdotes and rigorous clinical exploration, signaling a pivotal moment in the nation's healthcare trajectory. The deeply personal experience of a wealthy industrialist's family has, for instance, illuminated the potential of these advanced therapies. Following the untimely demise of his 71-year-old brother due to a cardiac event, the younger sibling, then 65, embarked on a deliberate quest for healthy aging. This journey led him to embrace cellular therapy as an annual regimen, often necessitating travel abroad for access to these specialized treatments. At 75, he not only maintains a remarkably active lifestyle but has also strategically invested in numerous biotechnology and stem cell research ventures, underscoring his conviction in their potential. His personal narrative has become a catalyst for broader discussions on how advanced therapies can contribute not just to extended lifespans but crucially, to an enhanced quality of life in later years. Echoing these individual successes, India itself is beginning to generate its own compelling case studies. A notable example is that of Mr. Pathak, a resident of Kanpur, who had grappled with uncontrolled diabetes for many years. Enrolled in a clinical program at GSVM Medical College, Pathak underwent a transplant utilizing adipose-derived stem cells adipose derived cellular concentrate. The outcome proved remarkable, exceeding even his own expectations. His HbA1c, a vital marker for long-term blood sugar control, saw a significant reduction from 9.5 to 6.5, achieved without substantial alterations to his existing medication regimen. This particular procedure was meticulously guided by Dr. B.S. Rajput , a visiting professor at GSVM Medical College and a distinguished consultant in orthopedic and cellular transplants. Dr. Rajput elucidated the methodology, stating, 'We carried out this cellular therapy using an Australian patented ultrasonic cavitation technology. This approach holds approval from the Drug Controller General of India for the management of pain in arthritis-affected knees.' He further emphasized a critical, often underestimated, aspect of healthy aging: 'When people can move without pain, their overall health outcomes improve significantly. Mobility is one of the most underrated factors in healthy aging. ' This highlights the intricate connection between pain management, mobility, and overall well-being in the aging process. The broader wellness and regenerative medicine industry in India is keenly observing these developments. Rajiv Chaturvedi, Vice President of Umbicell Pvt Ltd, a Mumbai-based healthcare firm, affirmed the accelerating awareness surrounding healthy aging. 'The next decade unequivocally belongs to wellness and longevity science. We are witnessing a greater societal acceptance of stem cell enhancers and joint health supplements, integrating them into everyday healthcare practices,' Chaturvedi commented. This indicates a growing consumer appetite and market readiness for innovative solutions in this domain. Beyond its foundational role in pain management, stem cell therapy's applications are progressively expanding. Researchers and clinicians are now exploring its efficacy for conditions once deemed intractable, including severe spinal cord injuries, debilitating muscular dystrophies, and even cerebral palsy in children. Dr. Rajput elaborated on these burgeoning areas: 'We are witnessing positive outcomes in cases once thought to have limited treatment options. While these remain closely monitored and clinically guided, the results offer substantive hope for a significantly improved quality of life for patients,' This expansion into complex neurological and musculoskeletal disorders underscores the transformative potential of regenerative approaches. Concurrently, research interest is branching into related, yet equally vital, areas such as gut health, which is increasingly recognized for its profound links to immunity and metabolic function. Varun Singh, Director of Scigenomics Pvt Ltd, a Navi Mumbai-based genomics and stem cell research laboratory, highlighted this symbiotic relationship. 'Gut wellness is emerging as a cornerstone of comprehensive anti-aging strategies. Our extensive microbiome testing work across Southeast Asia is instrumental in identifying precisely how gut bacteria influence not only digestion but also broader patterns of overall health and aging.' Singh stated. This interdisciplinary approach, integrating genomics and gut microbiome analysis, represents a holistic strategy toward understanding and mitigating the effects of aging. Globally, the anti-aging industry is projected to exceed USD 90 billion by the year 2030. India is poised to be a significant contributor to this substantial growth, propelled by its expanding middle class, increasing disposable incomes, and the continuous evolution of its healthcare infrastructure. While present challenges such as the high cost of therapies and limited accessibility remain pertinent, experts anticipate that wider adoption will naturally lead to reduced costs as research scales up and the underlying technologies mature, fostering greater affordability and reach. For the present, success stories like Pathak's remarkable improvement in diabetic control and the businessman's sustained vitality and activity well into his seventies are instrumental in reshaping public perception of longevity in India. These individual triumphs, synergistically combined with the rapid advancements in regenerative medicine, are fueling a more expansive public discourse. This conversation centers on aging not as an inevitable slide into infirmity but as a dynamic process that, with scientific intervention and responsible choices, can be actively managed for a better future. Dr. Rajput distilled the emerging philosophy succinctly. He commented, 'The science is ready, and awareness is unequivocally growing. If individuals approach these treatments responsibly, integrating prevention alongside therapy, then the goal of living longer, healthier, and more fulfilling lives can indeed become a realistic and attainable objective.' This forward-looking perspective underscores a shift from merely extending lifespan to fundamentally enhancing the quality of those additional years through informed and proactive health management. The above is non-editorial content and TIL does not guarantee, vouch or endorse any of it. Please take all steps necessary to ascertain that any information and content provided is correct, updated, and verified.
